Leif E. Pedersen

If you can Dream it, you can Do it !! ...Walt Disney

[Certara @Certara]

📢 Exciting news! Dr. Hugo Geerts, Head of Certara's QSP Neuroscience Modelling, will present at the Alzheimer's Association International Conference (AAIC) in Amsterdam, Netherlands from July 16-20. 🌍

Visit our conference landing page: https://t.co/WR1YVHNpGE

[Certara @Certara]

Trust the experts who have propelled over 500 oncology projects in 2021. Discover how Certara's biosimulation and regulatory strategy expertise can accelerate your path to success for your oncology drug program.

Learn more: https://t.co/SWr6Xe7JPR

[Certara @Certara]

Curious how international collaboration shapes the future of pediatric healthcare in Japan? Learn about the efforts being made to bridge the gaps in drug development for children. Read the blog here: https://t.co/eB3kAg176W

#Certara #DrugDevelopment #Pharmaceuticals

[Certara @Certara]

In Raj's Corner, Certara’s Senior Director, Dr. Rajesh Krishna shares expert blog posts on clinical pharmacology best practices. Discover the secrets to optimizing safety and efficacy while planning your drug's clinical development. https://t.co/TrFNh3vhTd

[Certara @Certara]

Calling all pharmaceutical researchers and scientists! Don't miss our exclusive webinar on Certara's Simcyp Discovery, the industry-leading platform for physiologically-based pharmacokinetic (PBPK) modeling. Register today: https://t.co/4UdFpMB4Fn

[Certara @Certara]

Learn about the latest technology in medical writing such as Data Integration and Structured Content Authoring with Trevor Standish. Trevor will share how medical writing teams are utilizing these capabilities to improve efficiency and quality. https://t.co/sU0Yu1RDSK

[Certara @Certara]

Developing drugs for rare diseases poses clinical, regulatory, & commercial challenges. Dive into this curated collection of case studies, webinars, blogs, & whitepapers to gain valuable insights & solutions for developing drugs for rare diseases. https://t.co/mcixKdzyNB

[Certara @Certara]

Interested in the latest insights on dose optimization for medications for vulnerable populations? This article offers a comprehensive analysis of the strategies and considerations for tailoring drug doses. Read it here: https://t.co/4zgN0MKU5x
#PharmaIndustry #DrugDevelopment

[Certara @Certara]

The celebrations continue! Our employees recently gathered at our Wilmington, DE office to proudly commemorate Certara’s 2023 Great Place To Work US Certification™! 🎊 #GPTW

[Certara @Certara]

How can repurposed data and advanced analytics validate surrogate endpoints? Discover how the Certara team utilized CODEx to analyze aggregated data from over 1000 clinical trials. https://t.co/Xvzs9CuCkH

#Certara #DataAnalysis #ClinicalTrials #Analytics #DrugDevelopment

[Certara @Certara]

We understand the challenges of budget cuts, rising development costs, & the demand for value-based healthcare. Explore our Market Access & Reimbursement Center to find a variety of literature & on-demand content covering the latest industry trends. https://t.co/vpBLdtA60c

[Certara @Certara]

A Global Risk Mitigation Plan can help ensure a successful drug launch. Learn how pharmaceutical and biotech companies can proactively identify and address potential barriers to market access, pricing, and more >> https://t.co/2Cob65HIad

#PharmaIndustry #DrugDevelopment

[Certara @Certara]

Calling all clinical trial experts! Interested in learning more about the CODEx platform? Our on-demand webinar recording is now available!

Watch it here: https://t.co/XXgquVqwzG

[Certara @Certara]

📢 Last chance to register for our webinar on July 19th! Discover the power of Model-Informed Drug Development (MIDD) and Model-Informed Formulation Development (MIFD). Learn how MIFD optimizes drug formulation using in silico modeling and simulation. 💊
https://t.co/Auq2EBbTls

[Certara @Certara]

Join our #webinar to experience the seamless integration of data into reports for enhanced traceability & explore the power of breaking down documents into reusable components to maximize writer focus and efficiency. https://t.co/VhNQAdAXtJ

[Certara @Certara]

Are you looking to enhance your understanding of pharmacokinetics in drug development? Join us for an enlightening webinar on Certara's Simcyp Discovery.

Reserve your spot now: https://t.co/AjxYReSXOx

#PharmaResearch #SimulationTools #Webinar

[Certara @Certara]

Attention pharmaceutical safety scientists! Discover Simcyp Secondary Intelligence™ V1.4, the best tool for accurate off-target drug safety evaluation. Achieve consistent risk assessment & anticipate adverse effects in #drugdevelopment & IND submission
https://t.co/29mBOJaHgQ

[Certara @Certara]

Congrats to Certara’s Pharmacometrics team and the team at Daiichi Sankyo for their recent publication on determining the optimal dose for an antibody-drug conjugate. Read it here: https://t.co/jbsVQvRyGI

#pharmacometrics, #oncologyresearch, #antibodytherapeutics

[Certara @Certara]

Eager to learn more about document insight extraction with CODEx Curate? The on-demand recording is now available for you to catch up!

Watch the webinar now. https://t.co/qleD2P3OZ3

[Certara @Certara]

This past week we kicked off the 2023 Residency and welcomed our 2nd year UNC fellows to their year at Certara. We are so excited to have these talented early career scientists with us and look forward to working alongside them.